IL-6 has been suggested as a state-related marker because it has increased during the acute phase and recent relapse-with previous antipsychotic use- and in patients with the first episode of psychosis without medication and has been normalized with long-term antipsychotic treatment. Here, IL6 is linked to psychotic disorder.